Asia
Jiangsu Bioperfectus Technologies Gets China Nod for Flu Virus Detection Kits
China's drug regulator granted Jiangsu Bioperfectus Technologies (SHA:688399) a medical device registration certificate for its in vitro diagnostic reagent for certain influenza types, according to a Thursday disclosure to the Shanghai bourse.The kit helps detect influenza A or the H1N1 2009 variant and seasonal H3 subtype influenza virus from human pharyngeal swab samples, the filing said.
SHA:688399
